EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) as a Biomarker for Radiation Dosimetry and Health Risk Assessment: A Review

Kave Moloudi, Traimate Sangsuwan iD, Satoru Monzen iD, Yohei Fujishima, Donovan Anderson iD, Benjamin Frey iD, Tomisato Miura iD, Samayeh Azariasl iD, Hiroshi Yasuda iD, Siamak Haghdoost iD

Antioxidants · 22.11.2025 · 14 (12) · 1393

DOI: 10.3390/antiox14121393 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 22.11.2025. Verfasst von Kave Moloudi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laser Research Centre, Faculty of Health Sciences, Doornfontein Campus, University of Johannesburg, Johannesburg 2028, South Africa. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the University of Caen Normandy within the Young researcher program, RadioDIFF in 2024 and, the Laboratoires Partenaires Internation…, University of Caen Normandy within the Young researcher program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nuclear factor erythroid 2-related factor 2 (NRF2) is a key transcription factor that controls the antioxidant response to oxidative stress, especially after exposure to ionizing radiation (IR). This review examines NRF2’s emerging role as a complementary biomarker in radiobiological dosimetry for assessing radiation exposure and its potential health effects. When cells encounter IR, the resulting reactive oxygen species (ROS) interfere with the NRF2 repressor KEAP1, leading to NRF2 activation and the expression of cytoprotective genes such as HO-1, NQO1, and GCLC. Evidence suggests that NRF2 levels increase in a dose- and time-dependent manner, primarily at low to moderate radiation doses, highlighting its potential for early detection of radiation exposure. However, at high doses (>8 Gy), NRF2 activation may be suppressed due to apoptosis or irreversible damage, which limits its reliability in those situations. The review also compares NRF2 with other biomarkers used in biodosimetry, discussing its advantages, such as sensitivity and early response, along with its limitations, including variability in activation at high doses and expression influenced by other oxidative factors. The authors introduce a comprehensive radiobiological model that illustrates how low-dose IR exposure affects NRF2 expression patterns, thereby improving the understanding of dose-dependent oxidative stress mechanisms. Additionally, the role of NRF2 in inflammation and general health risk assessment is emphasized, suggesting broader applications beyond biodosimetry. Overall, NRF2 holds significant promise for use in evaluating radiation exposure, developing radioprotection strategies, and informing future radiobiological research frameworks.

Schlagwörter

Stichwörter der Autor:innen

NRF2 factorbiodosimetrybiological modelingwhole-body exposure

Autor:innen und Institutionen

  • Laser Research Centre, Faculty of Health Sciences, Doornfontein Campus, University of Johannesburg, Johannesburg 2028, South Africa.
  • Laboratoire Aliments, Bioprocédés, Toxicologie Environnements (ABTE, UR4651), University of Caen, Normandy, Cedex 04, F-14050 Caen, France.
  • Advanced Resource Center for HADrontherapy in Europe (ARCHADE), F-14000 Caen, France.
  • Department of Health Sciences, Hirosaki University Graduate School of Health Sciences, Hirosaki University, Aomori-ken 036-8560, Japan.
  • Department of Risk Analysis and Biodosimetry, Institute of Radiation Emergency Medicine, Hirosaki University, Aomori-ken 036-8560, Japan.
  • Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.

ORCID-Profile: Traimate Sangsuwan, Satoru Monzen, Donovan Anderson, Benjamin Frey, Tomisato Miura, Samayeh Azariasl, Hiroshi Yasuda, Siamak Haghdoost

Förderung

  • This work was supported by the University of Caen Normandy within the Young researcher program, RadioDIFF in 2024 and, the Laboratoires Partenaires Internation…
  • University of Caen Normandy within the Young researcher program

Zitieren

APA

Moloudi, K., Sangsuwan, T., Monzen, S., Fujishima, Y., Anderson, D., Frey, B., Miura, T., Azariasl, S., Yasuda, H., & Haghdoost, S. (2025). Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) as a Biomarker for Radiation Dosimetry and Health Risk Assessment: A Review. Antioxidants, 14(12), 1393. https://doi.org/10.3390/antiox14121393

Vancouver

Moloudi K, Sangsuwan T, Monzen S, Fujishima Y, Anderson D, Frey B, et al. Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) as a Biomarker for Radiation Dosimetry and Health Risk Assessment: A Review. Antioxidants. 2025;14(12):1393. doi:10.3390/antiox14121393

BibTeX
@article{Moloudi2025,
  author = {Moloudi, Kave and Sangsuwan, Traimate and Monzen, Satoru and Fujishima, Yohei and Anderson, Donovan and Frey, Benjamin and Miura, Tomisato and Azariasl, Samayeh and Yasuda, Hiroshi and Haghdoost, Siamak},
  title = {Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) as a Biomarker for Radiation Dosimetry and Health Risk Assessment: A Review},
  journal = {Antioxidants},
  year = {2025},
  volume = {14},
  number = {12},
  pages = {1393},
  doi = {10.3390/antiox14121393}
}
Kostenlos starten →